{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:14:05Z","timestamp":1791335645070,"version":"4.3.1"},"reference-count":57,"publisher":"American Association for Cancer Research (AACR)","issue":"4","license":[{"start":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T00:00:00Z","timestamp":1680480000000},"content-version":"vor","delay-in-days":73,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012781","name":"Merck Sharp and Dohme","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012781","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Boehringer Ingelheim"},{"DOI":"10.13039\/501100008017","name":"Institut Gustave-Roussy","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008017","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Transgene"},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100016913","name":"MSDAVENIR","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016913","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007241","name":"Universit\u00e9 Paris-Saclay","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007241","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100015545","name":"Seerave Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015545","id-type":"DOI","asserted-by":"crossref"}]},{"name":"SIRIC"}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Cancer immunotherapy combinations have recently been shown to improve the overall survival of advanced mesotheliomas, especially for patients responding to those treatments. We aimed to characterize the biological correlates of malignant pleural mesotheliomas\u2019 primary resistance to immunotherapy and antiangiogenics by testing the combination of pembrolizumab, an anti\u2013PD-1 antibody, and nintedanib, a pan-antiangiogenic tyrosine kinase inhibitor, in the multicenter PEMBIB trial (NCT02856425). Thirty patients with advanced malignant pleural mesothelioma were treated and explored. Unexpectedly, we found that refractory patients were actively recruiting CD3+CD8+ cytotoxic T cells in their tumors through CXCL9 tumor release upon treatment. However, these patients displayed high levels of somatic copy-number alterations in their tumors that correlated with high blood and tumor levels of IL6 and CXCL8. Those proinflammatory cytokines resulted in higher tumor secretion of VEGF and tumor enrichment in regulatory T cells. Advanced mesothelioma should further benefit from stratified combination therapies adapted to their tumor biology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Sequential explorations of fresh tumor biopsies demonstrated that mesothelioma resistance to anti\u2013PD-1 + antiangiogenics is not due to a lack of tumor T-cell infiltration but rather due to adaptive immunosuppressive pathways by tumors, involving molecules (e.g., IL6, CXCL8, VEGF, and CTLA4) that are amenable to targeted therapies.<\/jats:p>\n                    <jats:p>This article is highlighted in the In This Issue feature, p. 799<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2159-8290.cd-22-0886","type":"journal-article","created":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T15:59:36Z","timestamp":1674230376000},"page":"858-879","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Genomic Instability and Protumoral Inflammation Are Associated with Primary Resistance to Anti\u2013PD-1 + Antiangiogenesis in Malignant Pleural Mesothelioma"],"prefix":"10.1158","volume":"13","author":[{"given":"Fran\u00e7ois-Xavier","family":"Danlos","sequence":"first","affiliation":[{"name":"1D\u00e9partement d'Innovation Th\u00e9rapeutique et d'Essais Pr\u00e9coces (DITEP), Gustave Roussy, Villejuif, France."},{"name":"2INSERM U1015 and CIC1428 BIOTHERIS, Gustave Roussy, Villejuif, France."},{"name":"3Facult\u00e9 de M\u00e9decine, Universit\u00e9 Paris-Saclay, Kremlin-Bicetre, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8303-3315","authenticated-orcid":false,"given":"Matthieu","family":"Texier","sequence":"additional","affiliation":[{"name":"4Service de Biostatistique et d\u2019\u00c9pid\u00e9miologie, Oncostat INSERM U1018, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2720-7664","authenticated-orcid":false,"given":"Bastien","family":"Job","sequence":"additional","affiliation":[{"name":"5Plateforme de Bioinformatique, Universit\u00e9 Paris-Saclay, INSERM US23, CNRS-UMS 3655, Gustave Roussy, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3264-6298","authenticated-orcid":false,"given":"Severine","family":"Mouraud","sequence":"additional","affiliation":[{"name":"2INSERM U1015 and CIC1428 BIOTHERIS, Gustave Roussy, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8373-041X","authenticated-orcid":false,"given":"Lydie","family":"Cassard","sequence":"additional","affiliation":[{"name":"6Laboratoire d'Immuno-Oncologie (LIO), CNRS-UMS 3655 and INSERM US23, Gustave Roussy, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0604-7614","authenticated-orcid":false,"given":"Capucine","family":"Baldini","sequence":"additional","affiliation":[{"name":"1D\u00e9partement d'Innovation Th\u00e9rapeutique et d'Essais Pr\u00e9coces (DITEP), Gustave Roussy, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1314-384X","authenticated-orcid":false,"given":"Andrea","family":"Varga","sequence":"additional","affiliation":[{"name":"1D\u00e9partement d'Innovation Th\u00e9rapeutique et d'Essais Pr\u00e9coces (DITEP), Gustave Roussy, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2239-6902","authenticated-orcid":false,"given":"Andrey A.","family":"Yurchenko","sequence":"additional","affiliation":[{"name":"7INSERM U981, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4175-3394","authenticated-orcid":false,"given":"Audrey","family":"Rabeau","sequence":"additional","affiliation":[{"name":"8Department of Medical Oncology, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0741-2118","authenticated-orcid":false,"given":"St\u00e9phane","family":"Champiat","sequence":"additional","affiliation":[{"name":"1D\u00e9partement d'Innovation Th\u00e9rapeutique et d'Essais Pr\u00e9coces (DITEP), Gustave Roussy, Villejuif, France."},{"name":"2INSERM U1015 and CIC1428 BIOTHERIS, Gustave Roussy, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1837-1745","authenticated-orcid":false,"given":"Diane","family":"Letourneur","sequence":"additional","affiliation":[{"name":"2INSERM U1015 and CIC1428 BIOTHERIS, Gustave Roussy, Villejuif, France."},{"name":"9\u00c9cole Normale Sup\u00e9rieure de Lyon, Universit\u00e9 Claude Bernard Lyon I, Universit\u00e9 de Lyon, Lyon, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1314-0913","authenticated-orcid":false,"given":"Delphine","family":"Bredel","sequence":"additional","affiliation":[{"name":"2INSERM U1015 and CIC1428 BIOTHERIS, Gustave Roussy, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2561-6528","authenticated-orcid":false,"given":"Sandrine","family":"Susini","sequence":"additional","affiliation":[{"name":"2INSERM U1015 and CIC1428 BIOTHERIS, Gustave Roussy, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4716-8017","authenticated-orcid":false,"given":"Yuna","family":"Blum","sequence":"additional","affiliation":[{"name":"10Institut de G\u00e9n\u00e9tique et D\u00e9veloppement de Rennes (IGDR), UMR6290 ERL U1305 CNRS, INSERM, Universit\u00e9 de Rennes, Rennes, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4147-4264","authenticated-orcid":false,"given":"Aurelien","family":"Parpaleix","sequence":"additional","affiliation":[{"name":"11Equipe Promotion \u2013 Bureau Projets et Promotion (BPP) \u2013 Direction de la Recherche Clinique (DRC), Gustave Roussy, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2427-5087","authenticated-orcid":false,"given":"Cedric","family":"Parlavecchio","sequence":"additional","affiliation":[{"name":"11Equipe Promotion \u2013 Bureau Projets et Promotion (BPP) \u2013 Direction de la Recherche Clinique (DRC), Gustave Roussy, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8878-4916","authenticated-orcid":false,"given":"Lambros","family":"Tselikas","sequence":"additional","affiliation":[{"name":"2INSERM U1015 and CIC1428 BIOTHERIS, Gustave Roussy, Villejuif, France."},{"name":"3Facult\u00e9 de M\u00e9decine, Universit\u00e9 Paris-Saclay, Kremlin-Bicetre, France."},{"name":"12D\u00e9partement d'Anesth\u00e9sie, Chirurgie et Imagerie Interventionnelle (DACII), Gustave Roussy, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6581-8418","authenticated-orcid":false,"given":"Jean-Eudes","family":"Fahrner","sequence":"additional","affiliation":[{"name":"2INSERM U1015 and CIC1428 BIOTHERIS, Gustave Roussy, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3431-3067","authenticated-orcid":false,"given":"Anne-Gaelle","family":"Goubet","sequence":"additional","affiliation":[{"name":"2INSERM U1015 and CIC1428 BIOTHERIS, Gustave Roussy, Villejuif, France."},{"name":"3Facult\u00e9 de M\u00e9decine, Universit\u00e9 Paris-Saclay, Kremlin-Bicetre, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2970-4821","authenticated-orcid":false,"given":"Mathieu","family":"Rouanne","sequence":"additional","affiliation":[{"name":"2INSERM U1015 and CIC1428 BIOTHERIS, Gustave Roussy, Villejuif, France."},{"name":"3Facult\u00e9 de M\u00e9decine, Universit\u00e9 Paris-Saclay, Kremlin-Bicetre, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7764-0677","authenticated-orcid":false,"given":"Saloomeh","family":"Rafie","sequence":"additional","affiliation":[{"name":"1D\u00e9partement d'Innovation Th\u00e9rapeutique et d'Essais Pr\u00e9coces (DITEP), Gustave Roussy, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2692-5162","authenticated-orcid":false,"given":"Alae","family":"Abbassi","sequence":"additional","affiliation":[{"name":"1D\u00e9partement d'Innovation Th\u00e9rapeutique et d'Essais Pr\u00e9coces (DITEP), Gustave Roussy, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2067-1840","authenticated-orcid":false,"given":"Ines","family":"Kasraoui","sequence":"additional","affiliation":[{"name":"13D\u00e9partement de Radiologie, Biomaps, UMR1281 INSERM, CEA, CNRS, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6895-1361","authenticated-orcid":false,"given":"Marie","family":"Breckler","sequence":"additional","affiliation":[{"name":"14INSERM US23, CNRS UAR 3655, AMMICa, Genomic Platform, Gustave Roussy Cancer Center, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9142-1868","authenticated-orcid":false,"given":"Siham","family":"Farhane","sequence":"additional","affiliation":[{"name":"1D\u00e9partement d'Innovation Th\u00e9rapeutique et d'Essais Pr\u00e9coces (DITEP), Gustave Roussy, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1506-0714","authenticated-orcid":false,"given":"Samy","family":"Ammari","sequence":"additional","affiliation":[{"name":"13D\u00e9partement de Radiologie, Biomaps, UMR1281 INSERM, CEA, CNRS, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0888-0842","authenticated-orcid":false,"given":"Salim","family":"Laghouati","sequence":"additional","affiliation":[{"name":"15Unit\u00e9 Fonctionnelle de Pharmacovigilance, Gustave Roussy, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6866-6787","authenticated-orcid":false,"given":"Anas","family":"Gazzah","sequence":"additional","affiliation":[{"name":"1D\u00e9partement d'Innovation Th\u00e9rapeutique et d'Essais Pr\u00e9coces (DITEP), Gustave Roussy, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2535-1010","authenticated-orcid":false,"given":"Ludovic","family":"Lacroix","sequence":"additional","affiliation":[{"name":"16D\u00e9partement de Biologie et Pathologie m\u00e9dicales, Plateforme de Biopathologie Mol\u00e9culaire, CNRS-UMS 3655 and INSERM US23, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5090-8189","authenticated-orcid":false,"given":"Benjamin","family":"Besse","sequence":"additional","affiliation":[{"name":"17D\u00e9partement de M\u00e9decine Oncologique, Gustave Roussy, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6099-5324","authenticated-orcid":false,"given":"Nathalie","family":"Droin","sequence":"additional","affiliation":[{"name":"14INSERM US23, CNRS UAR 3655, AMMICa, Genomic Platform, Gustave Roussy Cancer Center, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6352-101X","authenticated-orcid":false,"given":"Marc","family":"Deloger","sequence":"additional","affiliation":[{"name":"5Plateforme de Bioinformatique, Universit\u00e9 Paris-Saclay, INSERM US23, CNRS-UMS 3655, Gustave Roussy, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5598-0112","authenticated-orcid":false,"given":"Sophie","family":"Cotteret","sequence":"additional","affiliation":[{"name":"18Laboratoire de Cytog\u00e9n\u00e9tique, Gustave Roussy, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7556-9101","authenticated-orcid":false,"given":"Julien","family":"Adam","sequence":"additional","affiliation":[{"name":"19INSERM U1186, Gustave Roussy, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1596-0998","authenticated-orcid":false,"given":"Laurence","family":"Zitvogel","sequence":"additional","affiliation":[{"name":"2INSERM U1015 and CIC1428 BIOTHERIS, Gustave Roussy, Villejuif, France."},{"name":"3Facult\u00e9 de M\u00e9decine, Universit\u00e9 Paris-Saclay, Kremlin-Bicetre, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8587-2307","authenticated-orcid":false,"given":"Sergey I.","family":"Nikolaev","sequence":"additional","affiliation":[{"name":"7INSERM U981, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3968-8669","authenticated-orcid":false,"given":"Nathalie","family":"Chaput","sequence":"additional","affiliation":[{"name":"6Laboratoire d'Immuno-Oncologie (LIO), CNRS-UMS 3655 and INSERM US23, Gustave Roussy, Villejuif, France."},{"name":"20Facult\u00e9 de Pharmacie, Universit\u00e9 Paris-Saclay, Orsay, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5505-0564","authenticated-orcid":false,"given":"Christophe","family":"Massard","sequence":"additional","affiliation":[{"name":"1D\u00e9partement d'Innovation Th\u00e9rapeutique et d'Essais Pr\u00e9coces (DITEP), Gustave Roussy, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9597-0701","authenticated-orcid":false,"given":"Jean-Charles","family":"Soria","sequence":"additional","affiliation":[{"name":"21Amgen, Thousand Oaks, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8043-2529","authenticated-orcid":false,"given":"Carlos","family":"Gomez-Roca","sequence":"additional","affiliation":[{"name":"8Department of Medical Oncology, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0343-9575","authenticated-orcid":false,"given":"Gerard","family":"Zalcman","sequence":"additional","affiliation":[{"name":"22Service de Pneumologie, Hopital Bichat, APHP, Universit\u00e9 de Paris, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1565-8310","authenticated-orcid":false,"given":"David","family":"Planchard","sequence":"additional","affiliation":[{"name":"17D\u00e9partement de M\u00e9decine Oncologique, Gustave Roussy, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5816-3019","authenticated-orcid":false,"given":"Aurelien","family":"Marabelle","sequence":"additional","affiliation":[{"name":"1D\u00e9partement d'Innovation Th\u00e9rapeutique et d'Essais Pr\u00e9coces (DITEP), Gustave Roussy, Villejuif, France."},{"name":"2INSERM U1015 and CIC1428 BIOTHERIS, Gustave Roussy, Villejuif, France."},{"name":"3Facult\u00e9 de M\u00e9decine, Universit\u00e9 Paris-Saclay, Kremlin-Bicetre, France."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2023,1,20]]},"reference":[{"key":"2025121106432748300_bib1","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jtho.2015.11.005","article-title":"The 2015 World Health Organization classification of tumors of the pleura: advances since the 2004 classification","volume":"11","author":"Galateau-Salle","year":"2016","journal-title":"J Thorac Oncol"},{"key":"2025121106432748300_bib2","first-page":"5922","article-title":"Role of oxyradicals in mutagenicity and DNA damage induced by crocidolite asbestos in mammalian cells","volume":"59","author":"Xu","year":"1999","journal-title":"Cancer Res"},{"key":"2025121106432748300_bib3","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1126\/science.1156995","article-title":"Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica","volume":"320","author":"Dostert","year":"2008","journal-title":"Science"},{"key":"2025121106432748300_bib4","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J Clin Oncol"},{"key":"2025121106432748300_bib5","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1183\/09031936.00000811","article-title":"Predicting survival in malignant mesothelioma","volume":"38","author":"Musk","year":"2011","journal-title":"Eur Respir J"},{"key":"2025121106432748300_bib6","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrclinonc.2009.110","article-title":"Targeting angiogenesis: progress with anti-VEGF treatment with large molecules","volume":"6","author":"Grothey","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"key":"2025121106432748300_bib7","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"2025121106432748300_bib8","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N Engl J Med"},{"key":"2025121106432748300_bib9","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1056\/NEJMoa1816714","article-title":"Pembrolizumab plus axitinib versus sunitinib for advanced renal-cell carcinoma","volume":"380","author":"Rini","year":"2019","journal-title":"N Engl J Med"},{"key":"2025121106432748300_bib10","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1056\/NEJMoa1716948","article-title":"Atezolizumab for first-line treatment of metastatic nonsquamous NSCLC","volume":"378","author":"Socinski","year":"2018","journal-title":"N Engl J Med"},{"key":"2025121106432748300_bib11","doi-asserted-by":"crossref","first-page":"12624","DOI":"10.1038\/ncomms12624","article-title":"Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma","volume":"7","author":"Wallin","year":"2016","journal-title":"Nat Commun"},{"key":"2025121106432748300_bib12","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ebiom.2019.09.003","article-title":"Redefining malignant pleural mesothelioma types as a continuum uncovers immune-vascular interactions","volume":"48","author":"Alcala","year":"2019","journal-title":"EBioMedicine"},{"key":"2025121106432748300_bib13","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(15)01238-6","article-title":"Bevacizumab for newly diagnosed pleural mesothelioma in the mesothelioma avastin cisplatin pemetrexed study (MAPS): a randomised, controlled, open-label, phase 3 trial","volume":"387","author":"Zalcman","year":"2016","journal-title":"Lancet"},{"key":"2025121106432748300_bib14","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1200\/JCO.2017.72.9012","article-title":"Nintedanib plus pemetrexed\/cisplatin in patients with malignant pleural mesothelioma: phase II results from the randomized, placebo-controlled LUME-Meso trial","volume":"35","author":"Grosso","year":"2017","journal-title":"J Clin Oncol"},{"key":"2025121106432748300_bib15","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S2213-2600(19)30139-0","article-title":"Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothe\u00adlioma (LUME-Meso): a double-blind, randomised, placebo-controlled phase 3 trial","volume":"7","author":"Scagliotti","year":"2019","journal-title":"Lancet Respir Med"},{"key":"2025121106432748300_bib16","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S2213-2600(20)30515-4","article-title":"Efficacy and safety of pembrolizumab in patients with advanced mesothelioma in the open-label, single-arm, phase 2 KEYNOTE-158 study","volume":"9","author":"Yap","year":"2021","journal-title":"Lancet Respir Med"},{"key":"2025121106432748300_bib17","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1158\/2159-8290.CD-21-0331","article-title":"Efficacy, safety, and biomarker analysis of combined PD-L1 (atezolizumab) and VEGF (bevacizumab) blockade in advanced malignant peritoneal mesothelioma","volume":"11","author":"Raghav","year":"2021","journal-title":"Cancer Discov"},{"key":"2025121106432748300_bib18","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0140-6736(20)32714-8","article-title":"First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial","volume":"397","author":"Baas","year":"2021","journal-title":"Lancet"},{"key":"2025121106432748300_bib19","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S1470-2045(20)30462-9","article-title":"Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-in","volume":"21","author":"Nowak","year":"2020","journal-title":"Lancet Oncol"},{"key":"2025121106432748300_bib20","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1038\/s41591-021-01541-0","article-title":"Durvalumab with platinum-pemetrexed for unresectable pleural mesothelioma: survival, genomic and immunologic analyses from the phase 2 PrE0505 trial","volume":"27","author":"Forde","year":"2021","journal-title":"Nat Med"},{"key":"2025121106432748300_bib21","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1158\/2159-8290.CD-21-0407","article-title":"A phase I trial of regional mesothelin-targeted CAR T-cell therapy in patients with malignant pleural disease, in combination with the anti\u2013PD-1 agent pembrolizumab","volume":"11","author":"Adusumilli","year":"2021","journal-title":"Cancer Discov"},{"key":"2025121106432748300_bib22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cyto.2018.08.006","article-title":"Role of angiopoietins in mesothelioma progression","volume":"118","author":"Magkouta","year":"2019","journal-title":"Cytokine"},{"key":"2025121106432748300_bib23","doi-asserted-by":"crossref","first-page":"eaaz7252","DOI":"10.1126\/scitranslmed.aaz7252","article-title":"Enhanced efficacy of mesothelin-targeted immunotoxin LMB-100 and anti\u2013PD-1 antibody in patients with mesothelioma and mouse tumor models","volume":"12","author":"Jiang","year":"2020","journal-title":"Sci Transl Med"},{"key":"2025121106432748300_bib24","doi-asserted-by":"crossref","first-page":"e46091","DOI":"10.1371\/journal.pone.0046091","article-title":"Early detection of malignant pleural mesothelioma in asbestos-exposed individuals with a noninvasive proteomics-based surveillance tool","volume":"7","author":"Ostroff","year":"2012","journal-title":"PLoS One"},{"key":"2025121106432748300_bib25","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ejca.2020.06.009","article-title":"Chemokine biology on immune checkpoint-targeted therapies","volume":"137","author":"Letourneur","year":"2020","journal-title":"Eur J Cancer"},{"key":"2025121106432748300_bib26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1084\/jem.20140559","article-title":"VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors","volume":"212","author":"Voron","year":"2015","journal-title":"J Exp Med"},{"key":"2025121106432748300_bib27","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/nm1096-1096","article-title":"Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells","volume":"2","author":"Gabrilovich","year":"1996","journal-title":"Nat Med"},{"key":"2025121106432748300_bib28","doi-asserted-by":"crossref","first-page":"6808","DOI":"10.1158\/1078-0432.CCR-06-1558","article-title":"Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF-secreting cancer immunotherapy","volume":"12","author":"Li","year":"2006","journal-title":"Clin Cancer Res"},{"key":"2025121106432748300_bib29","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1158\/0008-5472.CAN-12-2325","article-title":"VEGFA-VEGFR pathway blockade inhibits tumor-induced regulatory T-cell proliferation in colorectal cancer","volume":"73","author":"Terme","year":"2013","journal-title":"Cancer Res"},{"key":"2025121106432748300_bib30","first-page":"55","article-title":"The role of interleukin-6 in malignant mesothelioma","volume":"4","author":"Rahim","year":"2015","journal-title":"Transl Lung Cancer Res"},{"key":"2025121106432748300_bib31","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3389\/fonc.2020.00126","article-title":"Antiangiogeneic strategies in mesothelioma","volume":"10","author":"Nowak","year":"2020","journal-title":"Front Oncol"},{"key":"2025121106432748300_bib32","first-page":"367","article-title":"Interleukin 8: an autocrine growth factor for malignant mesothelioma","volume":"59","author":"Galffy","year":"1999","journal-title":"Cancer Res"},{"key":"2025121106432748300_bib33","doi-asserted-by":"crossref","first-page":"6456","DOI":"10.18632\/oncotarget.27290","article-title":"Secretome of pleural effusions associated with non-small cell lung cancer (NSCLC) and malignant mesothelioma: therapeutic implications","volume":"10","author":"Donnenberg","year":"2019","journal-title":"Oncotarget"},{"key":"2025121106432748300_bib34","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/ijc.22006","article-title":"Interleukin-6 induces both cell growth and VEGF production in malignant mesotheliomas","volume":"119","author":"Adachi","year":"2006","journal-title":"Int J Cancer"},{"key":"2025121106432748300_bib35","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nrc.2017.42","article-title":"Novel insights into mesothelioma biology and implications for therapy","volume":"17","author":"Yap","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"2025121106432748300_bib36","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1158\/0008-5472.CAN-14-2305","article-title":"VEGF-A expression correlates with TP53 mutations in non-small cell lung cancer: implications for antiangiogenesis therapy","volume":"75","author":"Schwaederl\u00e9","year":"2015","journal-title":"Cancer Res"},{"key":"2025121106432748300_bib37","doi-asserted-by":"crossref","first-page":"695770","DOI":"10.3389\/fonc.2021.695770","article-title":"Homozygous co-deletion of type I interferons and CDKN2A genes in thoracic cancers: potential consequences for therapy","volume":"11","author":"Grard","year":"2021","journal-title":"Front Oncol"},{"key":"2025121106432748300_bib38","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1002\/1878-0261.13206","article-title":"Co-occurrence of CDKN2A\/B and IFN-I homozygous deletions correlates with an immunosuppressive phenotype and poor prognosis in lung adenocarcinoma","volume":"16","author":"Peng","year":"2022","journal-title":"Mol Oncol"},{"key":"2025121106432748300_bib39","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1172\/JCI117596","article-title":"Disruption by interferon-alpha of an autocrine interleukin-6 growth loop in IL-6-dependent U266 myeloma cells by homologous and heterologous down-regulation of the IL-6 receptor alpha- and beta-chains","volume":"94","author":"Schwabe","year":"1994","journal-title":"J Clin Invest"},{"key":"2025121106432748300_bib40","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s13046-022-02423-0","article-title":"Safety, recommended dose, efficacy and immune correlates for nintedanib in combination with pembrolizumab in patients with advanced cancers","volume":"41","author":"Baldini","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"2025121106432748300_bib41","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejca.2016.03.081","article-title":"RECIST 1.1-update and clarification: from the RECIST committee","volume":"62","author":"Schwartz","year":"2016","journal-title":"Eur J Cancer"},{"key":"2025121106432748300_bib42","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/cyto.a.23570","article-title":"Deep phenotyping of immune cell populations by optimized and standardized flow cytometry analyses","volume":"93","author":"Pitoiset","year":"2018","journal-title":"Cytometry A"},{"key":"2025121106432748300_bib43","doi-asserted-by":"crossref","first-page":"952","DOI":"10.12688\/f1000research.15398.1","article-title":"Swimming downstream: statistical analysis of differential transcript usage following Salmon quantification","volume":"7","author":"Love","year":"2018","journal-title":"F1000Res."},{"key":"2025121106432748300_bib44","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1093\/bioinformatics\/bty350","article-title":"Snakemake-a scalable bioinformatics workflow engine","volume":"34","author":"K\u00f6ster","year":"2018","journal-title":"Bioinformatics"},{"key":"2025121106432748300_bib45","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1093\/bioinformatics\/btw354","article-title":"MultiQC: summarize analysis results for multiple tools and samples in a single report","volume":"32","author":"Ewels","year":"2016","journal-title":"Bioinformatics"},{"key":"2025121106432748300_bib46","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nmeth.4197","article-title":"Salmon provides fast and bias-aware quantification of transcript expression","volume":"14","author":"Patro","year":"2017","journal-title":"Nat Methods"},{"key":"2025121106432748300_bib47","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"2025121106432748300_bib48","doi-asserted-by":"crossref","first-page":"i436","DOI":"10.1093\/bioinformatics\/btz363","article-title":"Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology","volume":"35","author":"Sturm","year":"2019","journal-title":"Bioinformatics"},{"key":"2025121106432748300_bib49","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"2025121106432748300_bib50","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"2025121106432748300_bib51","doi-asserted-by":"crossref","first-page":"11.10.1","DOI":"10.1002\/0471250953.bi1110s43","article-title":"From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline","volume":"43","author":"Van der Auwera","year":"2013","journal-title":"Curr Protoc Bioinformatics"},{"key":"2025121106432748300_bib52","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ng.806","article-title":"A framework for variation discovery and genotyping using next-generation DNA sequencing data","volume":"43","author":"DePristo","year":"2011","journal-title":"Nat Genet"},{"key":"2025121106432748300_bib53","doi-asserted-by":"crossref","first-page":"E2423","DOI":"10.1002\/humu.22771","article-title":"Oncotator: cancer variant annotation tool","volume":"36","author":"Ramos","year":"2015","journal-title":"Hum Mutat"},{"key":"2025121106432748300_bib54","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The sequence Alignment\/map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"2025121106432748300_bib55","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: efficient and comprehensive analysis of somatic variants in cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res"},{"key":"2025121106432748300_bib56","doi-asserted-by":"crossref","first-page":"e000147","DOI":"10.1136\/jitc-2019-000147","article-title":"Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project","volume":"8","author":"Merino","year":"2020","journal-title":"J Immunother Cancer"},{"key":"2025121106432748300_bib57","doi-asserted-by":"crossref","first-page":"16910","DOI":"10.1073\/pnas.1009843107","article-title":"Allele-specific copy number analysis of tumors","volume":"107","author":"Van Loo","year":"2010","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Cancer Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article-pdf\/doi\/10.1158\/2159-8290.CD-22-0886\/3262914\/cd-22-0886.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article-pdf\/doi\/10.1158\/2159-8290.CD-22-0886\/3281041\/cd-22-0886.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article-pdf\/13\/4\/858\/3319161\/858.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article-pdf\/13\/4\/858\/3319161\/858.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T11:43:44Z","timestamp":1765453424000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article\/13\/4\/858\/725020\/Genomic-Instability-and-Protumoral-Inflammation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,20]]},"references-count":57,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,1,20]]},"published-print":{"date-parts":[[2023,4,3]]}},"URL":"https:\/\/doi.org\/10.1158\/2159-8290.cd-22-0886","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/2159-8290.22494699.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22494723.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.c.6534585","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22494720.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22494726.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22553488.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22494708","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22494729.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22553458.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22494720","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22494699","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22553479","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22553467","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22553476.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22553467.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22494723","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22553485.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22494702.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22553482.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22553482","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22553470","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22494705.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22553461.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22494708.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22553464.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22553479.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22494711","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22553458","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22553473.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22494717.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22553470.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22494711.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22494714.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.c.6534585.v2","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22494702","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22494726","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22494714","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22553461","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22553485","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22553473","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.c.6534585.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22494717","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22494705","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22494729","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22553476","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22553464","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22553488","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2159-8290.30858971","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.30858959","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.30858947","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.30858962","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.30858974","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.30858965","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.30858953","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.30858941","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.30858944","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.30858968","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.30858956","asserted-by":"object"}]},"ISSN":["2159-8274","2159-8290"],"issn-type":[{"value":"2159-8274","type":"print"},{"value":"2159-8290","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,20]]}}}